Latest total current liabilities for NVOH: $1.1B.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
The latest total current liabilities for NVOH is $1.1B as of September 2016. That compares with $710M in the prior-year period — up 51.3% year over year. Investors often review this figure alongside Precidian ETFs Trust - Novo Nordisk A/S (B Shares) ADRhedged's historical trend and sector peers before judging valuation or financial health.
Over the past year, NVOH's total current liabilities moved from $710M to $1.1B — a 51.3% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Precidian ETFs Trust - Novo Nordisk A/S (B Shares) ADRhedged's operating scale or balance-sheet position.
A total current liabilities figure of $1.1B for NVOH is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.
After noting NVOH's total current liabilities ($1.1B), review year-over-year change from $710M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.